National Institute of Parasitic Diseases, China : 70 years and beyond /

Saved in:
Bibliographic Details
Imprint:London : Academic Press, 2020.
Description:1 online resource
Language:English
Series:Advances in parasitology ; v. 110
Advances in parasitology ; v. 110.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/12380125
Hidden Bibliographic Details
Other authors / contributors:Engels, Dirk.
Wang, Yu.
Zhou, Xiao-nong.
ISBN:9780128207536
0128207531
0128207523
9780128207529
Other form:Original 0128207523 9780128207529
Table of Contents:
  • Intro
  • National Institute of Parasitic Diseases, China: 70 Years and Beyond
  • Copyright
  • Contents
  • Contributors
  • Preface: Development strategy of NIPD-CTDR in the new era
  • 1. Foreword
  • 2. Major achievements
  • 2.1. Promoting parasitic diseases from control to elimination
  • 2.2. Promoting technological innovation in national medical parasitology
  • 2.3. Promoting the disciplinary development in tropical medicine and global health
  • 3. Future orientations
  • References
  • Chapter One: Contributions and achievements on schistosomiasis control and elimination in China by NIPD-CTDR
  • 1. Introduction
  • 2. The endemic status of schistosomiasis in P.R. China
  • 3. Transmission patterns and evolution of the control strategy on schistosomiasis
  • 3.1. Epidemiological patterns
  • 3.1.1. Plains & water network regions
  • 3.1.2. Marshlands & lakes regions
  • 3.1.2.1. Combination of sluice construction and snail control in the Poyang Lake
  • 3.1.2.2. Test for snail control by aircraft spraying
  • 3.1.3. Hilly & mountainous regions
  • 3.1.4. The influence of Three Gorges Dam on schistosomiasis transmission
  • 3.2. Strategy evolution
  • 3.2.1. The first stage, from the mid-1950s to the early 1980s
  • 3.2.2. The second stage, from the 1980s to the beginning of the 21st century
  • 3.2.3. The third stage, from 2004 to present
  • 4. Diagnostics and vaccine development
  • 4.1. Development and application of diagnostics
  • 4.1.1. Parasitological diagnosis
  • 4.1.1.1. Hatching test
  • 4.1.1.2. Improved Kato-Katz method combined with faecal hatching evaluation
  • 4.1.2. Immunological diagnosis
  • 4.1.2.1. The intradermal test
  • 4.1.2.2. Cercarien-Hullen-Reaktion
  • 4.1.2.3. The circumoval precipitin test
  • 4.1.2.4. Latex agglutination test
  • 4.1.2.5. Enzyme-linked immunoelectron transfer blot assay
  • 4.1.2.6. Enzyme-linked immunosorbent assay
  • 4.1.2.7. Rapid diagnostic kits
  • 4.1.3. Assessment of diagnostic assays and quality control
  • 4.1.3.1. Assessment of diagnostic assays
  • 4.1.3.2. Quality control
  • 4.2. Vaccines development
  • 4.2.1. Vaccine candidate antigens
  • 4.2.2. Multivalent vaccines
  • 4.2.3. Immunization test on cattle
  • 5. Research and development of drugs and molluscicides
  • 5.1. Drug development for human treatment
  • 5.1.1. Praziquantel
  • 5.1.1.1. Effect of praziquantel on the nervous system activity of schistosomes
  • 5.1.1.2. Effect of praziquantel on the metabolism of schistosomes
  • 5.1.1.3. Effect of praziquantel on the ultrastructure of different stages of schistosomes
  • 5.1.1.4. Comparison of the effects of different structures of praziquantel on schistosomes
  • 5.1.2. Artemether
  • 5.1.2.1. Mechanism of action
  • 5.1.2.2. Field trials
  • 5.1.3. Other new anti-schistosomiasis drugs
  • 5.2. Molluscicides development
  • 5.2.1. Bromoacetamide
  • 5.2.2. Niclosamide
  • 5.2.3. Development of novel chemical molluscicides